Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018

Abstract

In this analysis of branded drugs in the US from 2007 to 2018, mean increases in list and net prices were substantial, although discounts offset an estimated 62% of list price increases with substantial variation across classes.